Sanofi

News

LEO eyeing 2021 US launch for eczema drug tralokinumab

LEO Pharma is gearing up to launch its eczema drug tralokinumab next year after submitting a filing to the FDA, as it bids to take on Sanofi’s class rival Dupixent.

News

Kymera Therapeutics begins potential $2bn R&D deal with Sano...

US biotech Kymera Therapeutics has begun a strategic collaboration with Sanofi to develop and market several drugs tackling immune-inflammatory disease, which could be worth up to $2 billio

News

Kiadis Pharma and Sanofi to unlock power of natural killer c...

Sanofi has struck an exclusive rights deal with Dutch biotech Kiadis focused on combining modified natural killer cells with the French pharma’s blood cancer antibody Sarcl

News

GSK and Sanofi close in on £500m COVID-19 vaccine deal with ...

GlaxoSmithKline and Sanofi are close to agreeing a £500m deal to supply the UK government with 60 million doses of their potential coroanvirus vaccine, according to a press report.

News

Blood sample with respiratory coronavirus positive

IL-6 hypothesis looking shaky as Kevzara fails COVID-19 tria...

Hopes that already-approved drugs targeting IL-6 could be repurposed to treat COVID-19 have been undermined by disappointing results from the first large-scale trial of Sanofi

Partner Content

Hand Sanitizer Market will touch USD 3.6 billion by 2026

Global Hand Sanitizer Market size is projected to surpass USD 3.6 billion through 2026, growing at a CAGR of -2.4% for the period spanning from 2020 to 2026.

LEO eyeing 2021 US launch for eczema drug tralokinumab

Kymera Therapeutics begins potential $2bn R&D deal with Sano...

Kiadis Pharma and Sanofi to unlock power of natural killer c...

GSK and Sanofi close in on £500m COVID-19 vaccine deal with ...

IL-6 hypothesis looking shaky as Kevzara fails COVID-19 tria...

Hand Sanitizer Market will touch USD 3.6 billion by 2026

Ambros' $125m for pain disorder drug, and other financings

How to meet your physicians where they are online

Sanofi

Editor's Picks